Whistle Blower to receive $3.5 million dollars

Johnson & Johnson Unit to Pay $18 Million to Settle False Claims Act Allegations


Acclarent Inc., a subsidary of Johnson & Johnson has settled with the Department of Justice amid allegations that the Company marketed a sinus delivery device known as “Stratus” as a drug delivery device without FDA approval.  Acclarent only received FDA approval to use “Stratus” as a spacer used only with saline to maintain sinus openings following surgery.  However, “Stratus” was intended to be used as a drug-delivery device for prescription drugs.  Acclarent continued to use “Stratas” as a drug delivery device even after the FDA rejected the company’s request to expand “Stratas”‘s use in 2007.

Full article can be found by clicking here

Facebook Iconfacebook like buttonTwitter Icontwitter follow button